Skip to main content

Table 2 Independent T-test of mean and 95% CI for mean level of liver enzymes of study participant at Debre Behan Referral Hospital, Northeast Ethiopia

From: Liver enzyme elevation in patients taking HAART compared with treatment naïve controls at Debre Berhan Referral Hospital: a comparative cross-sectional study, Northeast Ethiopia

Parameter Study group Number Mean 95% CI for mean p-value
ALT (U/L) ART group 76 35.67 32.18–39.16 0.000*
Pre-ART group 76 23.97 21.38-26.57
AST (U/L) ART group 76 36.05 32.88–39.23 0.000*
Pre-ART group 76 28.00 25.52–30.49
ALP (U/L) ART group 76 117.14 97.99–136.30 0.022*
Pre-ART group 76 89.45 75.27–103.64
Total protein (g/dL) ART group 76 7.09 6.89–7.30 0.007*
Pre-ART group 76 7.46 7.29–7.64
Total bilirubin (mg/dL) ART group 76 0.787 0.761–0.813 0.000*
Pre-ART group 76 0.660 0.649–0.673
Direct bilirubin (mg/dL) ART group 76 0.275 0.227–0.324 0.007*
Pre-ART group 76 0.188 0.149–0.228
Urea (mg/dL) ART group 76 19.945 18.414–21.477 0.875
Pre-ART group 76 19.750 17.824–21.678
Creatinine (mg/dL) ART group 76 0.588 0.562–0.614 0.016*
Pre-ART group 76 0.641 0.607–0.675
Hemoglobin (g/dL) Treatment group 76 15.44 14.98–15.91 0.245
Pre-ART group 76 15.02 14.46–15.58
CD4 count (cells/µL) ART group 76 428.14 367.75–488.53 0.362
Pre-ART group 76 390.97 336.93–445.01
  1. * Statistically significant